3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
2
Unknown
1
Completed
1
Sponsor Class
UNKNOWN
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Nasopharyngeal Carcinoma
21
Prostatic Neoplasms
8
Breast Neoplasms
7
Head and Neck Neoplasms
6
Esophageal Squamous Cell Carcinoma
6
Esophageal Neoplasms
6
Rectal Neoplasms
4
Radiation Injuries
4
Carcinoma, Squamous Cell
4
Carcinoma, Non-Small-Cell Lung
4
Neoplasm Metastasis
3
Nasopharyngeal Neoplasms
3
Carcinoma, Hepatocellular
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Salivary Gland Neoplasms
2
Recurrence
2
Lung Neoplasms
2
Vulvar Neoplasms
1
Thyroid Neoplasms
1
Sinonasal undifferentiated carcinoma
1
Radiation
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Ototoxicity
1
Obesity
1
Neurotoxicity Syndromes
1
Neoplasms
1
Interventions
Methotrexate
3
Bevacizumab
3
osimertinib
2
aumolertinib
2
Pemetrexed
2
paclitaxel-Angiopep-2 conjugate
1
nimotuzumab
1
lorlatinib
1
glutathione pegylated liposomal doxorubicin
1
eribulin
1
envafolimab
1
durvalumab
1
camrelizumab
1
aflutinib
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Magnetic Resonance Spectroscopy
1
Immunoenzyme Techniques
1
Endostatins
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Meningeal Carcinomatosis
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT03027544
2017-01-23
TRBM
ChineseAMS
Phase NA
Unknown
150 enrolled